PARLIAMENTARY WRITTEN QUESTION
Pregnancy: Drugs (15 July 2022)

To ask the Secretary of State for Health and Social Care, with reference to the report entitled Healthy Mum, Healthy Baby, Healthy Future: The Case for UK Leadership in the Development of Safe Medicines for Use in Pregnancy, published in May 2022, if he will make an assessment of the implications for his policies of the recommendations in that report.

Asked by:
Feryal Clark (Labour)

The Department has noted the recommendations of the report. The Medicines and Healthcare products Regulatory Agency recently completed a public consultation on legislative powers to support diversity in clinical trial populations, including pregnancy and individuals who are breast feeding. The responses are being analysed and the Government’s response will be published later this year.

The Clinical Practice Research Datalink is currently being developed as a resource for studying the safety of medicines use in pregnancy via a new expanded Pregnancy Register. This includes anonymised data on 24.5 million pregnancy episodes in seven million women. The Registry will increase the ability to study rare exposures and outcomes and improve healthcare advice for women.

Answered by:
James Morris (Conservative)
25 July 2022